251
Views
0
CrossRef citations to date
0
Altmetric
Reviews

The pathogenesis of narcolepsy, current treatments and prospective therapeutic targets

, , &
Pages 63-82 | Published online: 19 Dec 2015
 

Abstract

Introduction: Narcolepsy is a chronic sleep disorder characterized by excessive daytime sleepiness (EDS), cataplexy and abnormal manifestations of rapid eye movement (REM) sleep such as sleep paralysis and hypnagogic hallucinations. Recent studies have demonstrated that narcolepsy–cataplexy is caused by the postnatal loss of hypocretin neurons (Type 1 narcolepsy), possibly because of autoimmune mechanisms. Although several new therapeutic options have recently been introduced, these new findings have not yet been incorporated to the therapies.

Areas covered: In this review, we first describe clinical symptoms and pathogenesis of narcolepsy. Second, we summarize the current knowledge about pharmacological treatments of narcolepsy and the modes of action of each drug. Finally, we discuss prospective therapeutic targets for narcolepsy.

Expert opinion: Current treatments are mostly symptomatic, but it is necessary to initiate the appropriate pharmacological treatment for each symptom with the understanding of pharmacological mechanisms. Development of synthetic hypocretin receptor agonists is the first and most urgent step for the improved treatment of Type 1 narcolepsy. Successes in this step will likely lead to developments of cell transplantation and gene therapies.

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access
  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 99.00 Add to cart
* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.